CIK: 1589712 - Address: 700 Quince Orchard Road, Gaithersburg, MD 20878
13 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
1/2/25 16:47
12/13/24
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagKing Rachel K.MDDS-379.020-4-2215D
6/14/24 16:07
6/12/24
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagKing Rachel K.MDDM.d00.00075419D
6/13/23 16:46
6/10/23
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagKing Rachel K.MDDM.d00.00033412D
6/21/22 20:46
6/17/22
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagKing Rachel K.MDDM.d00.000189D
8/20/21 17:29
6/25/21
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagKing Rachel K.MDDM.ad00.00031236D
6/29/21 17:14
6/25/21
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagKing Rachel K.MDDM.d00.000713812D
5/21/21 17:06
5/19/21
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagKing Rachel K.MDDP98139.6401165D
12/30/20 16:00
12/28/20
GLYCGlycomimetics IncDEHealthDrugPharmaceutical PreparationsKing Rachel K.MDDOP,CEOM.d1471.12013133531D
12/30/20 16:00
12/28/20
GLYCGlycomimetics IncDEHealthDrugPharmaceutical PreparationsKing Rachel K.MDDOP,CEOS.d-3293.910-84-14531D
8/7/19 16:29
8/6/19
GLYCGlycomimetics IncDEHealthDrugPharmaceutical PreparationsKing Rachel K.MDDOP,CEOM.d1871.12016752485D
3/28/19 16:21
3/27/19
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagKing Rachel K.MDDP460.529808664M
2/26/15 17:02
2/24/15
GLYCGlycomimetics IncDEHealthDrugPharmaceutical PreparationsKing Rachel K.MDDOP,CEOM.d561.1205019318D-364-1116135111-30-15-43
6/20/14 16:00
6/18/14
GLYCGlycomimetics IncDEHealthDrugPharmaceutical PreparationsKing Rachel K.MDDOP,CEOM.d1121.12110060268D-49-261911-10-75-517-1

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact